As we stated in the meta-analysis, we think that further prospective studies are necessary to determine variations of these preclinical parameters after the normalization of excess GH and IGF-1, and to identify their precise role in development of atherosclerosis and cardiovascular risk. The gene discussed is GH1; the disease is atherosclerosis.